Dr. Holterman is a medical practitioner keen on the development of technology and finding the cure for illnesses such as diabetes. He is an alumnus of the Virginia University and also lectures surgery and Pediatrics at the University of Illinois. Dr. Holterman is a member of various boards such as the American Diabetes Association (ADA), IPSAC, and Mariam global health.
IPSAC relies on donors and volunteers to improve healthcare and Pediatric surgical care. Volunteers who chose this program offer their support through patient care, training lecturing and surgery at medical schools in Vietnam. These volunteers must possess a visa valid for six months, a copy of professional license and resume. Once these conditions are met, the volunteers traveled to Vietnam and briefed on the proceedings and their period of stay.
Dr. Mark Holterman is the CEO of Mariam Global Health which has strong interests in the development of cell-based therapies. The Congress passed a bill which funds support for generative medicine (Facebook). The act also helps in the fast-tracking of drug approval procedures.it provides efficient FDA approval process for certain stem cells practices.
Dr. Holterman is behind the establishment of Hannah Sunshine Foundation. The organization aims to use cellular regenerative therapies for children with rare diseases. The primary disease of focus for this institution is Systematic Juvenile Idiopathic Arthritis (SJIA). The condition not only affects the joints but other body organs such as the lungs, liver, and heart. The condition mainly affects children and currently does not have a cure however efforts are being put forth to deal with it. The organization alongside cellular therapies created cellular and regenerative therapies. The organization utilizes stem cells when conducting therapies (easily found in body fat tissues) they are often taken from the bone marrow and placental tissues. The cells can grow into many different cells and help in combating inflammation, improve healing, stopping cellular decaying forming new blood vessels.
Mark Holterman received an award, which indicates his accomplishment in the field of Diabetes Care. The organization is pressed to funding research into diabetes cure and prevention measures. The recipients of the award must have an innovative hypothesis that is related to the pathology of diabetes and demonstrates the significant progress concerning diabetes treatment and prevention. With all these organizations, Dr. Mark Holterman contribution toward the development of medicine cannot be overlooked but glorified with the highest honors.